Generic Name and Formulations:
Ivermectin 3mg, 6mg+; tabs; +scored.
Merck & Co., Inc.
Indications for STROMECTOL:
Intestinal strongyloidiasis due to Strongyloides stercoralis. Onchocerciasis due to immature Onchocerca volvulus.
Adults and Children:
Take with water. Give as a single dose. <15kg: not recommended. Strongyloidiasis: 200mcg/kg. Onchocerciasis: 150mcg/kg; may retreat after 3 months.
Hyperreactive onchodermatitis. Immunocompromised. Pregnancy (Cat.C), nursing mothers: not recommended.
Strongyloidiasis: dizziness, pruritus, GI disturbances. Onchocerciasis: Mazzotti reactions (eg, arthralgia/synovitis, swollen lymph nodes), ophthalmologic effects, pruritus, rash, fever, tachycardia, edema, hypotension.
Tabs 3mg—20; 6mg—10
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- Psychological Therapies May Help Older Adults With Chronic Pain
- Traumatic Brain Injury Linked to Increased Parkinson Disease Risk in Veterans
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics